CATALAYER NEWS

Italy's Alfasigma pens $690M deal for GSK itching drug awaiting FDA approval decision - Fierce Biotech

Source: Fierce Biotech · 2026-03-09

Full article text is available in the Catalayer news terminal.

RELATED ON CATALAYER
Related Topics
EV & Auto Industry NewsBiotech & FDA News
RELATED MARKETS
Prediction Markets
Xi Jinping out before 2027?5%Will Gavin Newsom win the 2028 Democratic presidential nomination?14%Will Alexandria Ocasio-Cortez win the 2028 Democratic presidential nomination?21%
Open Catalayer terminal for live tracking →